Stay updated on Emapalumab in Adult HLH: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Emapalumab in Adult HLH: Efficacy & Safety Clinical Trial page.

Latest updates to the Emapalumab in Adult HLH: Efficacy & Safety Clinical Trial page
- Check3 days agoChange DetectedKey documents including the Statistical Analysis Plan and Study Protocol were removed from the Study Documents section, along with related items such as IPD plans.SummaryDifference17%

- Check10 days agoChange DetectedRevision note updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedAdded a Locations section displaying the Houston, Texas site (MD Anderson Cancer Center). Removed the HHS Vulnerability Disclosure footer link and the Texas Locations label, and updated the page revision to v3.3.3.SummaryDifference0.2%

- Check60 days agoChange DetectedFooter revision note updated from v3.2.0 to v3.3.2. This metadata change does not alter any study information or content.SummaryDifference0.1%

- Check67 days agoChange DetectedThe government funding/operating status notice was removed from the page; core trial information and study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedMinor cosmetic updates to the Study Details page, including header layout and typography; core study data such as eligibility criteria, interventions, and outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Emapalumab in Adult HLH: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emapalumab in Adult HLH: Efficacy & Safety Clinical Trial page.